Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.40
Delayed Data
As of May 29
 +0.21 / +2.06%
Today’s Change
8.84
Today|||52-Week Range
18.48
-26.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line-22.4M-35.3M-40.3M-27.7M
 
 
 
 
 
Depreciation56.0K97.0K121.0K138.0K
 
 
 
 
 
Total Other Cash Flow2.6M8.2M13.6M4.3M
 
 
 
 
 
Funds From Operations-19.8M-27.0M-25.9M-23.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.2M-7.2M7.7M12.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-17.6M-19.8M-33.6M-35.3M
 
 
 
 
 
 
InvestingIncrease In Investments4.5M-4.5M-46.0K0.00
 
 
 
 
Decrease In Investments173.0K15.3M22.6M11.5M
 
 
 
 
 
Capital Expenditures-565.0K-413.0K-290.0K-61.0K
 
 
 
 
 
Net Cash Flow Investing4.1M10.5M22.3M11.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale264.0K1.4M-6.1M126.6M
 
 
 
 
 
Common Preferred Redeemed-65.0K0.007.5M-8.2M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing199.0K1.4M1.4M118.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-13.3M-7.9M-9.8M94.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account